SCHEMBL9951719

SCHEMBL9951719

C[n+]1ccc(/C=C/c2cccc(C=O)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHAT P28329 9/20 0.64
▸ ALDH1A1 P00352 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ GLA P06280 1/20 0.54
▸ RAB9A P51151 5/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ APOBEC3A P31941 1/20 0.46
▸ APOBEC3G Q9HC16 1/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ ALPG P10696 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ THRB P10828 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30988353 1.00 CHAT (0.64) CHATALDH1A1MAPTSMN1; SMN2GLA
SCHEMBL1901832 1.00 CHAT (0.64) CHATALDH1A1MAPTSMN1; SMN2GLA
SCHEMBL4625849 0.82 CHAT (0.61) CHATALDH1A1MAPTSMN1; SMN2GLA
SCHEMBL300426 0.82 CHAT (0.61) CHATALDH1A1MAPTSMN1; SMN2GLA
SCHEMBL6527327 0.80 ALDH1A1 (0.59) ALDH1A1LMNA
SCHEMBL6527325 0.80 ALDH1A1 (0.59) ALDH1A1LMNA
SCHEMBL1907271 0.80 RAB9A (0.57) CHATALDH1A1MAPTRAB9AKDM4E
SCHEMBL29620209 0.80 RAB9A (0.57) CHATALDH1A1MAPTRAB9AKDM4E
SCHEMBL1980757 0.80 RAB9A (0.57) CHATALDH1A1MAPTRAB9AKDM4E
Benzene SCHEMBL4555522 0.78 CHAT (0.60) CHATALDH1A1MAPTSMN1; SMN2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11369559-B2 Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer L'OREAL (FR) 2022-06-28 — — US disclosed
US-20220087920-A1 COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION L'OREAL (FR) 2022-03-24 — — US disclosed
CN-108367167-B Method for treating keratin materials using a composition comprising a modified photodimerisable polymer 莱雅公司 2021-12-31 — — CN disclosed
EP-3897858-A1 COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION L'OREAL (FR) 2021-10-27 — — EP disclosed
CN-113195058-A Composition comprising a modified photodimerisable polymer and an alkaline agent and/or an aminoalkoxysilane derivative and treatment process for implementing the composition 莱雅公司 2021-07-30 — — CN disclosed
EP-3393592-B1 A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER OREAL (FR) 2021-06-09 — — EP disclosed
WO-2020127230-A1 COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION L'OREAL (FR) 2020-06-25 — — WO disclosed
US-20190000743-A1 A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER L'OREAL (FR) 2019-01-03 — — US disclosed
EP-3393592-A1 A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER L'OREAL (FR) 2018-10-31 — — EP disclosed
WO-2017108767-A1 A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER L'OREAL (FR) 2017-06-29 — — WO disclosed
EP-2654712-B1 STERILE LIQUID COMPOSITION FOR FILLING WRINKLES L'ORÉAL (FR) 2017-02-22 — — EP disclosed
EP-2654712-A2 STERILE LIQUID COMPOSITION FOR FILLING WRINKLES L'Oréal (FR) 2013-10-30 — — EP disclosed
WO-2012085835-A2 STERILE LIQUID COMPOSITION FOR FILLING WRINKLES L'OREAL (FR) 2012-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190000743-A1 A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER KRT18, KRTCAP2, CKAP4 CHAT 3691/4885ALDH1A1 1833/4885MAPT 26/4885
US-20220087920-A1 COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER AND AN ALKALINE AGENT AND/OR AN AMINO ALKOXYSILANE DERIVATIVE AND TREATMENT METHOD IMPLEMENTING THE COMPOSITION ACP1, ALAD, PHOSPHO1 CHAT 4101/4885ALDH1A1 2122/4885MAPT 714/4885
US-11369559-B2 Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer KRT18, KRTCAP2, CKAP4 CHAT 3810/4885ALDH1A1 2099/4885MAPT 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback